News

Gladstone in the News October 5, 2020

What We Know about Trump’s Extraordinary COVID-19 Treatment

San Francisco Chronicle—After the president was diagnosed with COVID-19, he received aggressive medical treatment. Gladstone Senior Investigator Warner Greene noted that the combination of drugs the president received has not been tested or proven effective, and that the dexamethasone he was given is a sign his illness might be more severe than it appears.

Gladstone Experts COVID-19 Infectious Disease Greene Lab

Gladstone in the News October 4, 2020

Long COVID: The Evidence of Lingering Heart Damage

The Guardian—Recent work from Senior Investigators Todd McDevitt, PhD, and Bruce Conklin, MD, documenting the damaging effect of SARS-CoV-2 on heart cells is mentioned in a detailed review of the long-term impact of COVID-19 on patients’ hearts.

Gladstone Experts COVID-19 Cardiovascular Disease Data Science and Biotechnology Conklin Lab McDevitt Lab

Article October 2, 2020

Should You Get a Flu Shot This Year in the Midst of the COVID-19 Pandemic?

The answer is yes. And here’s why.

Gladstone Experts COVID-19 Center for HIV Cure Research Infectious Disease Greene Lab

Gladstone in the News October 2, 2020

Next Wave of Bay Area Neuroscience Companies: What Are They Doing Now?

San Francisco Business Times—Gabaeron, founded by Gladstone President Emeritus Bob Mahley, MD, PhD, and Therini Bio (formerly Medared), founded upon work by Senior Investigator Katarina Akassoglou, PhD, are among Bay Area biotech companies focusing on neurological diseases that collectively raised more than $3 billion from venture capital firms and the public capital markets in 2020.

Gladstone Experts Parkinson’s Disease Multiple Sclerosis Alzheimer’s Disease Neurological Disease Akassoglou Lab Mahley Lab

Gladstone in the News October 2, 2020

Genetic Network that Differentiates Regulatory T Cells Mapped

Clinical Omics—Alex Marson, MD, PhD, director of the Gladstone-UCSF Institute of Genomic Immunology, explains his lab's recent discovery of the the gene networks that distinguish regulatory T cells from other types of T cells, and the implication for therapies against cancer and autoimmune diseases.

Gladstone Experts Autoimmune Diseases Marson Lab

Gladstone in the News October 1, 2020

Researchers Uncover How Sars-Cov-2 Inflicts Damage on Heart Cells

Technology Network—Senior Investigator Bruce Conklin, MD, explains how SARS-CoV-2 damages heart cells and how heart cells grown in the lab could be used to screen for drugs against infection by the novel coronavirus.

Gladstone Experts COVID-19 Cardiovascular Disease Conklin Lab

Gladstone in the News October 1, 2020

Immune System Gene Braking Discovery Opens Doors to New Cancer Therapies

Genetic Engineering and Biotechnology News—Alex Marson, MD, PhD, director of the Gladstone-UCSF Institute of Genomic Immunology, explains the implications of his lab's recent identification of gene networks that control the function of immune cells, known as regulatory T cells, for therapies against cancer and autoimmune diseases.

Gladstone Experts Autoimmune Diseases Genomic Immunology Marson Lab

Article October 1, 2020

Gladstone Researchers Awarded $3.2 Million to Study Cellular Energy

Ken Nakamura and Todd McDevitt will study how to boost cells’ energy and how the strategy can best treat disease

Grants Cardiovascular Disease Neurological Disease McDevitt Lab Nakamura Lab

Article September 30, 2020

Scientists Map Genes Controlling Immune System “Brakes”

The findings help point toward drug targets for new immune therapies to treat cancer and autoimmune disease

Genomic Immunology Marson Lab

Gladstone in the News September 30, 2020

“Berlin Patient” Dies at 54: Timothy Ray Brown, the First Man Cured of HIV, Succumbs to Leukemia

San Francisco Chronicle—Warner Greene, MD, PhD, director of the Center for HIV Cure Research, explains how Timothy Ray Brown, who was cured of HIV/AIDS via a bone marrow transplant, changed the field of HIV research.

Gladstone Experts HIV/AIDS Center for HIV Cure Research Greene Lab

Video September 30, 2020

Black, Brown, Bruised: How Racialized STEM Education Stifles Innovation

Learn how your institution can have a profound impact on traditionally underrepresented people working in the field—while pushing innovation further than ever before.

Gladstone Experts Diversity

Article September 29, 2020

A First In-Depth Look at the Latent Virus Reservoir of Individuals Living with HIV

New study opens avenues for studying or targeting the main barrier to a cure

News Release Research (Publication) HIV/AIDS Infectious Disease Roan Lab

Gladstone in the News September 28, 2020

New abdominal aortic aneurysm genes identified, could help pinpoint those at risk

heart.org News—A study of U.S. veterans identified 14 genes that may predict the risk of abdominal aortic aneurysm.

Tcheandjieu Lab

Gladstone in the News September 26, 2020

CRISPR Screening Identifies Human Host Pathways That Facilitate Coronavirus Infection

Life Science—The online science news hub Life Sciences highlights recent work from Senior Investigators Melanie Ott, MD, PhD, and Nevan Krogan, PhD, and their colleagues at BioHub and Synthego Corporation. The work describes the identification of host factors common to three coronaviruses including SARS-CoV-2, and could help bootstrap efforts to stem current and future coronavirus epidemics.

Gladstone Experts COVID-19 Data Science and Biotechnology Infectious Disease Krogan Lab Ott Lab CRISPR/Gene Editing

Gladstone in the News September 22, 2020

Some Covid-19 Patients Show Signs of Heart Damage Months Later

The Wall Street Journal—Senior Investigator Todd McDevitt, PHD, comments on the damage SARS-CoV-2 can inflict on heart cells, which he and Senior Investigator Bruce Conklin, MD, recently reported in an article deposited on bioRxiv.

Gladstone Experts COVID-19 Cardiovascular Disease Data Science and Biotechnology Conklin Lab McDevitt Lab